Traws Pharma, Inc. (NASDAQ:TRAW) Q2 2025 Earnings Call Transcript August 14, 2025
Traws Pharma, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-8.75.
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Traws Pharma, Inc. Second Quarter 2025 Financial Results and Business Update Call. [Operator Instructions] As a reminder, this call is being recorded today, August 14, 2025. At this time, I’d like to turn the call over to John Fraunces of...
